<SEC-DOCUMENT>0001214659-25-001513.txt : 20250129
<SEC-HEADER>0001214659-25-001513.hdr.sgml : 20250129
<ACCEPTANCE-DATETIME>20250129060808
ACCESSION NUMBER:		0001214659-25-001513
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250129

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Radiopharm Theranostics Ltd
		CENTRAL INDEX KEY:			0001949257
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94814
		FILM NUMBER:		25566502

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 3, 62 LYGON STREET
		CITY:			CARLTON VIC
		STATE:			C3
		ZIP:			3053
		BUSINESS PHONE:		61 3 9824 5254

	MAIL ADDRESS:	
		STREET 1:		LEVEL 3, 62 LYGON STREET
		CITY:			CARLTON VIC
		STATE:			C3
		ZIP:			3053

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			REGAL FUNDS MANAGEMENT PTY LTD
		CENTRAL INDEX KEY:			0001569369
		ORGANIZATION NAME:           	
		STATE OF INCORPORATION:			C3

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 47, GATEWAY
		STREET 2:		1 MACQUARIE PLACE
		CITY:			SYDNEY NSW
		STATE:			C3
		ZIP:			2000
		BUSINESS PHONE:		612-8197 4333

	MAIL ADDRESS:	
		STREET 1:		LEVEL 47, GATEWAY
		STREET 2:		1 MACQUARIE PLACE
		CITY:			SYDNEY NSW
		STATE:			C3
		ZIP:			2000
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: REGAL FUNDS MANAGEMENT PTY LTD -->
          <cik>0001569369</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Ordinary Shares, no par value and American Depositary Shares, each representing three hundred Ordinary Shares, no par value</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001949257</issuerCik>
        <issuerName>Radiopharm Theranostics Limited</issuerName>
        <issuerCusip>75041J101</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>Suite 1 Level 3</com:street1>
          <com:street2>62 Lygon Street</com:street2>
          <com:city>Carlton South, Victoria</com:city>
          <com:stateOrCountry>C3</com:stateOrCountry>
          <com:zipCode>3053</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Regal Funds Management Pty Limited</reportingPersonName>
      <citizenshipOrOrganization>C3</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>175080633.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>175080633.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>175080633.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>7.96</classPercent>
      <typeOfReportingPerson>FI</typeOfReportingPerson>
      <comments>The number of shares beneficially owned includes: (i) 147,807,933 Ordinary Shares, no par value ("Ordinary Shares") and (ii) 90,909 American Depositary Shares, each representing three hundred Ordinary Shares.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Radiopharm Theranostics Limited</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>Suite 1 Level 3, 62 Lygon Street, Carlton South, Victoria, Australia 3053</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Regal Funds Management Pty Limited and Regal Partners Limited</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Level 47, Gateway, 1 Macquarie Place, Sydney NSW 2000</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Australian</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>HC</typeOfPersonFiling>
        <typeOfPersonFiling>FI</typeOfPersonFiling>
        <otherTypeOfPersonFiling>FI</otherTypeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>175,080,633</amountBeneficiallyOwned>
        <classPercent>7.96</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>0</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>175,080,633</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>175,080,633</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Regal Funds Management Pty Limited</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Kenny Ho</signature>
        <title>Company Secretary</title>
        <date>01/29/2024</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
